Safety and efficacy of the MDR inhibitor incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer
Randall P. Rago, Albert Einstein, Richard Lush, Tomasz M. Beer, Yoo Joung Ko, W. David Henner, Glenn Bubley, Elizabeth A. Merica, Varun Garg, Ene Ette, Matthew W. Harding, William S. Dalton
Dive into the research topics of 'Safety and efficacy of the MDR inhibitor incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer'. Together they form a unique fingerprint.